Lu Jiade
Medical Oncology
Languages Spoken： Mandarin 、EN 、
National High-Level Talent, National Distinguished Expert, Chief Scientist of the National Key R&D Program; Professor at Soochow University, Clinical Oncology Professor at Fudan University; Former Executive Vice President of Shanghai Proton and Heavy Ion Hospital, Former Vice President of Singapore General Hospital; Member of the Steering Committee of Heyou International Hospital Group, Vice President of Heyou Hospital; Director of the Oncology Medical Center and Proton and Heavy Ion Center, Heyou Hospital.
Be Good at
Prof. Lu specializes in precise radiation therapy and multidisciplinary comprehensive treatment of tumors. He holds authoritative expertise in the diagnosis and treatment of head and neck tumors, central nervous system tumors, and gastrointestinal tumors. He has edited and published multiple oncology textbooks and guidelines globally.
-
Academic Achievements
-
Editor-in-Chief of the Springer Radiation Oncology Series Guidelines -
Lead and Chief Scientist of a key R&D program of the Ministry of Science and Technology
-
Currently serves as Editor-in-Chief of the book series "Medical Radiology: Radiation Oncology" and "Clinical Practice Guidelines in Radiation Oncology"
-
Developed nearly 10 guidelines for radiation oncology through the book series "Clinical Practice Guidelines in Radiation Oncology"
-
Edited and published 14 monographs and textbooks in both Chinese and English, including "Radiation Oncology: An Evidence-Based Approach"
-
Edited and published multiple Chinese oncology monographs: "Advances in the Treatment of Common Malignancies", "Advances in the Diagnosis and Treatment of Common Malignancies Series", and "Advances in the Diagnosis and Treatment of Common Malignancies Series - Nasopharyngeal Carcinoma"
-
Published over 100 papers in top domestic and international medical journals in recent years
-
All published papers are indexed in SCI journals or Chinese core journals
-
Representative journal publications include papers in Journal of Clinical Oncology, Cancer, and Head and Neck
-
-
Social Position
-
2020: Awarded the Shanghai Magnolia Silver Honor Award for outstanding contributions to the management of Shanghai Proton and Heavy Ion Center -
international exchange, and the development and application of proton and heavy ion radiotherapy technology for tumors.
-
2019: Recognized as an
-
Technical Leader
-
2018: Received the Shanghai
-
2017: Awarded the Shanghai Magnolia Memorial Award for outstanding contributions to the management of Shanghai Proton and Heavy Ion Center and the development and application of proton and heavy ion radiotherapy technology for tumors.
-
2016: Named
-
2015: Recognized as an 11th Batch National Distinguished Expert.
-
2014: Recognized as a 4th Batch Shanghai Distinguished Expert.
-
2001: Received the Research Award from the Radiological Society of North America (RSNA) for clinical research achievements (during residency).
-